Thromboprophylaxis for patients with cancer and central venous catheters

200883 citationsReview

Authors

Elie A. Akl · University at Buffalo, State University of New York

Ganesh Kamath · University at Buffalo, State University of New York

Victor E D Yosuico · University at Buffalo, State University of New York

Seoyoung C. Kim · University at Buffalo, State University of New York

Maddalena Barba

Francesca Sperati

Deborah J. Cook · Samaritan Hospital

Holger J. Schünemann

Abstract

The balance of benefits and downsides of thromboprophylaxis in cancer patients with CVC are uncertain. Clinicians together with their patients must weigh these factors carefully when making decisions regarding thromboprophylaxis.

Topics & Keywords

Venous Thromboembolism Diagnosis and Management Central Venous Catheters and Hemodialysis Atrial Fibrillation Management and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer

Volume 112, Issue 11, pp. 2483-2492

DOI: 10.1002/cncr.23479

Field-Weighted Citation Impact: 3.91